IPO

Brightstar Lottery's expansion into Pennsylvania with its Cash Pop game and a new $20 price point isn't just a launch—it's a calculated bet on a new player.

With a $10M loan and a SPAC deal, Everli is betting on tech and partnerships to win Italy's competitive online grocery market. But can it deliver profits?

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

A new $300M blank check company is hunting for the foundational tech of the decentralized web. Is this the smart money's bet on crypto's next boom?

The junior explorer is terminating its NWA project option to double down on promising uranium anomalies in Wyoming and a major conductive corridor in Athabasca.

Beyond a simple payout, Qnity Electronics' increased dividend reveals its deep financial strength and strategic position fueling the AI and HPC revolution.

Coveo manages a key executive transition by doubling down on its AI-driven growth story, reassuring investors that its innovation engine remains in high gear.

Apollo Commercial Real Estate Finance offers a tempting 10% yield, but can it last? We dive into the risks and rewards of this high-stakes CRE play.

Condor Energies secures $10M in a high-stakes financing to fast-track its Uzbekistan gas program. A deep dive into the strategy, risks, and what it means.

A routine dividend from Morgan Stanley's China A-Share fund offers a deeper look into the risks and rewards of investing in China's domestic market.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

OTC-listed Lelantos Holdings, known for renewables, bets its future on a historic Arizona gold-copper mine. A strategic pivot or a high-stakes gamble?

An Auckland firm is using Meta Smart Glasses for pest inspections, giving clients an unprecedented look inside their walls and setting a new standard for transparency.

A Chinese firm's entry into Germany's EV market seems distant from medicine, but its tricycle vehicle could be the key to a greener, faster last-mile for healthcare.

Destra's fund is boosting distributions by over 21%. We dissect the proprietary strategy driving this yield and the risks investors must consider.

Klaviyo appoints a veteran scaler as co-CEO in a bold move to let its founder focus solely on AI. Is this the new leadership model for tech dominance?